Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-215-4 | CAS number: 68037-92-3 This substance is identified by SDA Substance Name: C16-C22 alkyl amine and SDA Reporting Number: 21-029-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-09-02 to 2011-10-31
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Amines, C16-22-alkyl
- EC Number:
- 268-215-4
- EC Name:
- Amines, C16-22-alkyl
- Cas Number:
- 68037-92-3
- Molecular formula:
- CnH2n+3N with n={16; 18; 20; 22}
- IUPAC Name:
- C16-22-(even numbered)-alkyl-1-amine
- Details on test material:
- Name: C16-22-(even numbered)alkylamines
CAS No.: 68037-92-3
Chemical Name: C16-22-(even numbered)alkylamines
Batch No.: S001453
Physical State at RT: solid
Colour: white to yellow
pH: 11.5 at 5% in ethanol:water (1:1) DIN EN 1262
Active Components: (for further details see CoA dated 12.07.2011, attached in the appendix of the report)
Date of Analysis: 12 July 2011
Storage Conditions: put nitrogen gas into bottle before closing it to prevent test item from oxidizing
Expiry Date: at least to 20180421
Constituent 1
Method
- Target gene:
- The five strains of Salmonella typhimurium (a): TA 1535, TA 1537, TA 98, TA 100 and TA 102. Each strain derived from Salmonella typhimurium LT 2 contains one mutation in the histidine operon, resulting in a requirement for histidine.
In addition, to increase their sensitivity to mutagenic items, further mutations have been added:
• the rfa mutation causes partial loss of the lipopolysaccharide barrier that coats the surface of
the bacteria and increases permeability to large molecules that do not penetrate the normal
bacteria cell wall,
• the uvrB mutation is a deletion of a gene coding for the DNA excision repair system, which
renders the bacteria unable to use this repair mechanism to remove the damaged DNA,
• the addition of the plasmid pKM 101 to strains TA 98, TA 100 and TA 102 enhances their
sensitivity of detection to some mutagens,
• in case of TA 102 strain, the histidine mutation is located on the multicopy plasmid pAQ1.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat S9 liver microsomal fraction
- Test concentrations with justification for top dose:
- Determination of dose was determined in pre-experiment of r toxicity.
Experiment I:
3.16, 10.0, 31.6, 100, 316 and 1000 µg/plate
Experiment II:
1.58, 5.00, 15.8, 50.0, 158 and 500 µg/plate
(TA 98 without metabolic activation)
1.58, 5.00, 15.8, 50.0, 158, 500 and 1000 µg/plate
(all tester strains except TA 98 without metabolic activation)
The toxicity of the test item was determined with testerstrainsTA98andTA100inapre-experiment. Eight concentrations were tested for toxicity and induction of mutations with three plates each. The experimental conditions in this pre-experiment were the same as described below for the main experiment I (plate incorporation test). Toxicity may be detected by a clearing or rather diminution of the background lawn or are duction in the number of revertants down to a mutation factor of approximately ≤0.5 in relation to the solvent control. The test item was tested in the pre-experiment with the following concentrations: 3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol ApplichemLotNo.1R002540
- Negative controls (A.dest., BSL BIOSERVICE Lot No. 110728, 110927,111010)
Controls
- Untreated negative controls:
- yes
- Remarks:
- A. dest., BSL Lot No. 110728, 110927, 111010 - All tester strains
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol, Lot No. Applichem Lot No. 1R002540 - All tester strains
- Positive controls:
- yes
- Positive control substance:
- other:
- Remarks:
- Positive control without metabolic activation: sodium azide for tester strains TA100, TA1535; 4-nitro-o-phenylene-diamine for TA98, TA1537; methylmethanesulfonate for TA102. Positive control with metabolic activation: 2-aminoanthracene for all strains
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: at least 48 h; After solidification the plates were inverted and incubated at 37 °C for at least 48 h in the dark.
NUMBER OF REPLICATIONS: For each strain and dose level, including the controls, three plates were used (in three cases only two plates were evaluated)
DETERMINATION OF CYTOTOXICITY
- Method: clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control - Evaluation criteria:
- The Mutation Factor is calculated by dividing the mean value of the revertant counts through the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs
in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and TA 102 the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher
than the reversion rate of the solvent control. - Statistics:
- According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
SD of means derived for all test items and controls.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Precipitation of the test item was observed in all tester strains used in experiment I and II. In experiment I precipitation of the test item was found at a concentration of 316 ug/plate and higher (with and without metabolic activation), in experiment II precipitation of the test item was found at a concentration of 500 ug/plate and higher (with and without metabolic activation).
Toxic effects of the test item were noted in all tester strains evaluated in experiment I and ll.
In experiment I toxic effects of the test item were observed in tester strain TA 98 at a concentration of 1000 ug/plate (with and without metabolic activation). In tester strain TA 100 toxic effects of the test item were seen at a concentration Of 1000 ug/plate (without metabolic activation). In tester strains TA 1535, TA 1537 and TA 102 toxic effects of the test item were noted at concentrations of 316 ug/plate and higher (without metabolic activation).
In experiment Il toxic effects of the test item were noted in tester strain TA 98 at a concentration Of 500 ug/plate (without metabolic activation) and at a concentration Of 1000 pg/plate (with metabolic activation). In tester strains TA 100 and TA 1535 toxic effects of the test item were noted at concentrations of 158 ug/plate and higher (without metabolic activation). In tester strain TA 1537 toxic effects of the test item were observed at concentrations of 500 ug/plate and higher (without metabolic activation) and at a concentration of 1000 ug/plate (with metabolic activation). In tester strain TA 102 toxic effects Of the test item were observed at a concentrations Of 1000 ug/plate (without metabolic activation). The reduction in the number of revertants down to a mutation factor of 0.5 found in experiment II in tester strain TA 98 at a concentration of 50.0 ug/plate (without metabolic activation) was regarded as not biologically relevant due to lack of a dose-response relationship, No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with C16-22-(even numbered)alkylamines at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II. The reference mutagens induced a ,distinct increase of revertant colonies indicating the validity of the experiments.
Experiment 1:
TA 98 untreated controls, A. dest., showed a mean revertant count per plate of 22 (SD 7.5) and 18 (SD 4) with and without S9 respectively. TA 98 negative controls, EtOH, showed a mean revertant count per plate of 27 (SD 1) and 21 (SD 4) with and without S9 respectively. The highest mutation factor was 1.2 (3.16, 10 31.6 ug) and 1.1 (3.16 ug) with and without S9 respectively. Positive control of 4-NOPD without S9 resulted in a mutation factor of 16.0. Positive control of 2-AA with S9 resulted in a mutation factor of 93.5.
TA 100 untreated controls, A. dest., showed a mean revertant count per plate of 113 (SD 7) and 110 (SD 13.2) with and without S9 respectively. TA 100 negative controls, EtOH, showed a mean revertant count per plate of 102 (SD 12.7) and 97 (SD 21.7) with and without S9 respectively. The highest mutation factor was 1.1 (316 ug) and 1.3 (100 ug) with and without S9 respectively. Positive control of NaN3 without S9 resulted in a mutation factor of 12.6. Positive control of 2-AA with S9 resulted in a mutation factor of 26.5.
TA 1535 untreated controls, A. dest., showed a mean revertant count per plate of 8 (SD 1.7) and 11 (SD 1.5) with and without S9 respectively. TA 1535 negative controls, EtOH, showed a mean revertant count per plate of 13 (SD 6.4) and 9 (SD 2) with and without S9 respectively. The highest mutation factor was 1.4 (3.16 ug) and 1.4 (10 ug) with and without S9 respectively. Positive control of NaN3 without S9 resulted in a mutation factor of 111.7. Positive control of 2-AA with S9 resulted in a mutation factor of 15.2.
TA 91537 untreated controls, A. dest., showed a mean revertant count per plate of 7 (SD 2.6) and 5 (SD 1.5) with and without S9 respectively. TA 1537 negative controls, EtOH, showed a mean revertant count per plate of 7 (SD 3.5) and 7 (SD 3.1) with and without S9 respectively. The highest mutation factor was 1.9 (100 ug) and 1.6 (10 ug) with and without S9 respectively. Positive control of 4-NOPD without S9 resulted in a mutation factor of 11.3. Positive control of 2-AA with S9 resulted in a mutation factor of 43.2.
TA 102 untreated controls, A. dest., showed a mean revertant count per plate of 340 (SD 21.1) and 268 (SD 19.0) with and without S9 respectively. TA 102 negative controls, EtOH, showed a mean revertant count per plate of 306 (SD 35.7) and 272 (SD 19.3) with and without S9 respectively. The highest mutation factor was 1.3 (10 and 31.6 ug) and 1.1 (3.16 ug) with and without S9 respectively. Positive control of MMS without S9 resulted in a mutation factor of 5.5. Positive control of 2-AA with S9 resulted in a mutation factor of 2.7.
Experiment 2:
TA 98 untreated controls, A. dest., showed a mean revertant count per plate of 34 (SD 6.4) and 28 (SD 7.5) with and without S9 respectively. TA 98 negative controls, EtOH, showed a mean revertant count per plate of 41 (SD 15.0) and 32 (SD 4.9) with and without S9 respectively. The highest mutation factor was 1.1(15.8 ug) and 1.0 (1.58 and 5 ug) with and without S9 respectively. Positive control of 4-NOPD without S9 resulted in a mutation factor of 12.2. Positive control of 2-AA with S9 resulted in a mutation factor of 63.7.
TA 100 untreated controls, A. dest., showed a mean revertant count per plate of 127 (SD 13.9) and 122 (SD 4.9) with and without S9 respectively. TA 100 negative controls, EtOH, showed a mean revertant count per plate of 131 (SD 10.8) and 105 (SD 4.7) with and without S9 respectively. The highest mutation factor was 1.1 (158 ug) and 1.2 (1.58 ug) with and without S9 respectively. Positive control of NaN3 without S9 resulted in a mutation factor of 7.4. Positive control of 2-AA with S9 resulted in a mutation factor of 11.9.
TA 1535 untreated controls, A. dest., showed a mean revertant count per plate of 10 (SD 4.4) and 10 (SD 2.1) with and without S9 respectively. TA 1535 negative controls, EtOH, showed a mean revertant count per plate of 11 (SD 1.2) and 9 (SD 1.2) with and without S9 respectively. The highest mutation factor was 1.5 (158 ug) and 1.6 (5 ug) with and without S9 respectively. Positive control of NaN3 without S9 resulted in a mutation factor of 117.2. Positive control of 2-AA with S9 resulted in a mutation factor of 13.5.
TA 91537 untreated controls, A. dest., showed a mean revertant count per plate of 10 (SD 2.1) and 11 (SD 4.7) with and without S9 respectively. TA 1537 negative controls, EtOH, showed a mean revertant count per plate of 13 (SD 3.5) and 6 (SD 2.6) with and without S9 respectively. The highest mutation factor was 1.4 (158 ug) and 1.6 (50 ug) with and without S9 respectively. Positive control of 4-NOPD without S9 resulted in a mutation factor of 20.3. Positive control of 2-AA with S9 resulted in a mutation factor of 27.1.
TA 102 untreated controls, A. dest., showed a mean revertant count per plate of 345 (SD 7.6) and 271 (SD 30.6) with and without S9 respectively. TA 102 negative controls, EtOH, showed a mean revertant count per plate of 358 (SD 34.3) and 275 (SD 27.3) with and without S9 respectively. The highest mutation factor was 1.1 (1.58 ug) and 1.2 (15.8 ug) with and without S9 respectively. Positive control of MMS without S9 resulted in a mutation factor of 4.3. Positive control of 2-AA with S9 resulted in a mutation factor of 2.1. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
For results data see study report. Statistical significance in subsqent tables does not account for reduction in background lawn or observed cytotoxicity.
Table 1.1: Experiment I Mean Revertant Colonies per Plate
| Treatment | Without S9 | With S9 | ||||||||
Strain |
| TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 |
Experiment I Mean (Standard Deviation) | Aqua destillata (untreated) | 18 (4.0) | 110 (13.2) | 11 (1.5) | 5 (1.5) | 268 (19.0) | 22 (7.5) | 113 (7.0) | 8 (1.7) | 7 (2.6) | 340 (21.1) |
EtOH (negative control) | 21 (4.0) | 97 (21.7) | 9 (2.0) | 7 (3.1) | 272 (19.3) | 27 (1.0) | 102 (12.7) | 13 (6.4) | 7 (3.5) | 306 (35.7) | |
Test Item 3.16 µg | 24 (8.1) | 92 (5.1) | 9 (1.5) | 5 (4.0) | 293 16.2 | 31 (4.9) | 97 (16.5) | 18 (6.2) | 10 (4.6) | 370 39.9 | |
Test Item 10 µg | 18 (1.5) | 92 (4.4) | 13 (3.0) | 11 (4.2) | 275 (21.5) | 34 (1.5) | 106 (11.7) | 12 (5.8) | 9 (4.6) | 406* (20.0) | |
Test Item 31.6 µg | 22 (1.5) | 113 (15.5) | 11 (5.0) | 7 (2.0) | 275 (21.5) | 32 (8.2) | 100 (23.2) | 12 (4.0) | 9 (4.6) | 404* (12.5) | |
Test Item 100 µg | 19 (3.1) | 128 (8.7) | 10 (1.5) | 4 (0.6) | 266 (34.1) | 27 (5.1) | 103 (9.0) | 15 (5.1) | 13 (4.0) | 337 (28.0) | |
Test Item 316 µg | 23 (3.6) | 108 (2.9) | 4† (3.5) | 4 (1.0) | 266† (34.1) | 31 (3.6) | 107 (10.1) | 13* (0.0) | 9 (2.0) | 336 (29.0) | |
Test Item 1000 µg | 6† (2.1) | 80 (15.6) | 4† (1.7) | 3 (3.5) | 218 (27.8) | 11 (2.0) | 92 (12.3) | 10 (2.9) | 4 (1.0) | 332 (59.5) | |
2-AA (Positive Control) |
|
|
|
|
| 2525* (251.4) 2.5µg | 2696* (188.6) 2.5µg | 203* (15.5) 2.5µg | 288* (37.7) 2.5µg | 839* (159.1) 10µg | |
4-NOPD (Positive Control) | 341* (21.0) 10µg |
|
| 75* (18.5) 40µg |
|
|
|
|
|
| |
NaN3 (Positive Control) |
| 1227* (63.1) 10µg | 1005* (108.1) 10µg |
|
|
|
|
|
|
| |
MMS (Positive Control) |
|
|
|
| 1488* (169.7) 1µL |
|
|
|
|
|
* Statistically significant increase over that of the negative control p≤0.05
† Statistically significant decrease over that of the negative control p≤0.05
(#) Standard deviation
Table 1.2: Experiment II Mean Revertant Colonies per Plate
| Treatment | Without S9 | With S9 | ||||||||
Strain |
| TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 |
Experiment II Mean (Standard Deviation) | Aqua destillata (untreated) | 28 (7.5) | 122 (4.9) | 10 (2.1) | 11 (4.7) | 271 (30.6) | 34 (6.4) | 127 (13.9) | 10 (4.4) | 10 (2.1) | 345 (7.6) |
EtOH (negative control) | 32 (4.9) | 105† (4.7) | 9 (1.2) | 6 (2.6) | 275 (27.3) | 41 (15.0) | 131 (10.8) | 11 (1.2) | 13 (3.5) | 358 (34.3) | |
Test Item 1.58 µg | 31 (6.8) | 122 (16.0) | 10 (1.0) | 8 (3.2) | 294 (14.3) | 30 (4.4) | 137 (11.1) | 14 (1.2) | 12 (0.0) | 382* (21.7) | |
Test Item 5 µg | 32 (6.8) | 119 (9.6) | 14 (3.8) | 14 (3.6) | 280 (55.7) | 34 (4.2) | 130 (8.5) | 15 (2.6) | 12 (1.0) | 343 (4.5) | |
Test Item 15.8 µg | 27 (4.0) | 105† (6.7) | 6† (0.0) | 7 (2.1) | 319 (15.9) | 46 (24.9) | 136 (27.1) | 10 (1.2) | 12 (2.5) | 319† (9.3) | |
Test Item 50 µg | 17 (8.3) | 102† (7.5) | 9 (4.4) | 9 (2.5) | 270 (35.4) | 35 (6.7) | 123 (10.1) | 15 (3.0) | 17* (3.2) | 295 (42.0) | |
Test Item 158 µg | 21 (5.9) | 90† (17.5) | 3 (3.5) | 8 (3.2) | 246 (31.0) | 32 (6.7) | 143 (9.9) | 16 (3.5) | 18* (4.0) | 289† (13.6) | |
Test Item 500 µg | 17 (2.9) | 65† (20.8) | 4† (1.5) | 5 (1.5) | 242 (43.2) | 29 (8.1) | 130 (17.6) | 14 (1.7) | 8 (1.0) | 316† (10.3) | |
Test Item 1000 µg |
| 59† (20.4) | 6 (2.8) | 6 (3.5) | 227 (3.6) | 8 (5.0) | 125 (14.2) | 13 (4.7) | 5 (2.0) | 256 (37.9) | |
2-AA (Positive Control) |
|
|
|
|
| 2613* (282.2) 2.5µg | 1557* (643.7) 2.5µg | 144* (7.9) 2.5µg | 361* (7.0) 2.5µg | 761* (103.2) 10µg | |
4-NOPD (Positive Control) | 385* (72.3) 10µg |
|
| 122* (4.0) 40µg |
|
|
|
|
|
| |
NaN3 (Positive Control) |
| 775* (351.3) 10µg | 1015* (27.0) 10µg |
|
|
|
|
|
|
| |
MMS (Positive Control) |
|
|
|
| 1192* (101.1) 1µL |
|
|
|
|
|
* Statistically significant increase over that of the negative control p≤0.05
† Statistically significant decrease over that of the negative control p≤0.05
(#) Standard deviation
Table 3: Mean revertant colonies for negative and untreated controls
| Metabolic activation | Without S9 | With S9 | ||||||||
Strain | TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | |
Experiment I (Mean count) | Aqua destillata (untreated) | 18 | 110 | 11 | 5 | 268 | 22 | 113 | 8 | 7 | 340 |
EtOH (negative control) | 21 | 97 | 9 | 7 | 272 | 27 | 102 | 13 | 7 | 306 | |
Experiment II (Mean count) | Aqua destillata (untreated) | 28 | 122 | 10 | 11 | 271 | 34 | 127 | 10 | 10 | 345 |
EtOH (negative control) | 32 | 105 | 9 | 6 | 275 | 41 | 131 | 11 | 13 | 358 |
Historical control data is as follows:
Table 4: HLC - Negative control without S9
TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | |
Mean | 23.3 | 117.9 | 12.4 | 9.9 | 243.3 |
SD | 4.2 | 31.2 | 4.8 | 3.7 | 51.0 |
Min | 16 | 77 | 5 | 5 | 164 |
Max | 46 | 174 | 29 | 28 | 399 |
RSD % | 18.2 | 26.5 | 38.4 | 37.4 | 21.0 |
n= | 852 | 871 | 804 | 802 | 531 |
Table 5: HLC - Positive control without S9
TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | |
Mean | 500.1 | 1029.1 | 1140.8 | 130.3 | 1512.9 |
SD | 139.1 | 260.9 | 266.9 | 28.5 | 336.2 |
Min | 250 | 316 | 94 | 43 | 391 |
Max | 2613 | 2307 | 1850 | 249 | 2353 |
RSD % | 27.8 | 25.4 | 23.4 | 21.9 | 22.2 |
n= | 825 | 849 | 777 | 775 | 517 |
Table 6: HLC - Negative control with S9
TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | |
Mean | 30.8 | 116.6 | 9.7 | 10.4 | 270.4 |
SD | 5.5 | 17.4 | 3.1 | 3.7 | 57.9 |
Min | 18 | 80 | 5 | 5 | 163 |
Max | 56 | 165 | 27 | 34 | 458 |
RSD % | 17.7 | 14.9 | 32.0 | 36.0 | 21.4 |
n= | 853 | 872 | 804 | 802 | 531 |
Table 7: HLC - Positive control with S9
TA 98 | TA 100 | TA 1535 | TA 1537 | TA 102 | |
Mean | 2424.9 | 1945.7 | 144.1 | 252.4 | 1120.7 |
SD | 589.1 | 589.0 | 68.9 | 86 | 328.0 |
Min | 423 | 495 | 28 | 58 | 419 |
Max | 3599 | 3341 | 582 | 474 | 2422 |
RSD % | 24.3 | 30.3 | 47.8 | 34.1 | 29.3 |
n= | 826 | 847 | 777 | 775 | 516 |
Liturature
(1). Ames, B.N., Durston, W.E., Yamasaki, E. and Lee, F.D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection Proc. Nat\. Acad. Sci. (USA) 70, 2281-2285
(2). Ames, B.N., McCann, J. and Yamasaki, E. (1977) Methods of detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test In: BJ. Kilbey et a\. (Eds.) "Handbook of Mutagenicity Test Procedures" Elsevier, Amsterdam, 1-17
(3). Claxton, L.D., Allen, J., Auletta, A., Mortelmans, K., Nestmann, E. and Zeiger, E. (1987). Guide for the Salmonella typhimurium/mammalian microsome tests for bacterial mutagenicity. Mutat. Res. 189,83-91
(4). Gatehouse D., Haworth, S., Cebula, T., Gocke, E., Kier, L., Matsushima, T., Melcion, C., Nohmi, T., Ohta, T., Venitt, S., Zeiger, E. (1994) Recommendation for the performance of bacterial mutation assays Mutation Res. 312,217-233
(5). Kier, L.E., Brusick, DJ., Auletta, A.E., von Halle, E.S., Brown, M.M., Simmon, V.F., Dunkel, V., McCann, 1., Mortelmans, K., Prival, M., Rao, T.K. and Ray, V. (1986) The Salmonella typhimurium/mammalian microsomal assay. A report ofthe U.S. Environmental Protection Agency Gene-Tox-Program Mutat. Res. 168, 69-240
(6). Maron, D.E. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173-215.
(7). McCann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 Chemicals. Proc. Nat\. Acad. Sci. (USA) 72, 5135-5139
(8). McCann,1. and Ames, B.N. (1976) Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 Chemicals: Discussion.' Proc. Nat\. Acad. Sci. (USA) 73, 950-954
(9). Mortelsmans, K. and Zeiger, E. (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 455, 29-60
(10). Zeiger, E., Haseman, J., Shelby, M., Margolin, B. and Tennant, R. (1988) Salmonella mutagenicity tests IV. Results from testing of 300 Chemicals Environ. Mol. Mutagen., 11, 1-158
(11). Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. and Mortelmanns, K. (1992) Salmonella mutagenicity tests V. Results from the testing of 311 Chemicals Environ. Mol. Mutagen. 19 (Suppl. 21),2-141
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, C16-22-(even numbered)alkylamines did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, C16-22-(even numbered)alkylamines is considered to be non-mutagenic in this bacterial reverse mutation assay. - Executive summary:
Introduction
This study followed the procedures indicated by internal BSL BIOSERVICE SOPs and the following internationally accepted guidelines and recommendations:
OECD Guidelines for Testing of Chemicals, No. 471, "Bacterial Reverse Mutation Test", adopted 21st July, 1997
Commission Regulation (EC) No. 440/2008 B.13/14:"Mutagenicity - Reverse Mutation Test using Bacteria", dated May 30, 2008
EPA Health Effects Test Guidelines, OPPTS 870.5100 "Bacterial Reverse Mutation Assay" EPA 712-C-98-247, August 1998This study was conducted to comply with OECD Principles of Good Laboratory Practice (as revised in 1997).
The princilple of this study was to investigate the potential of CI6-22-(even numbered)alkylamines for its ability to induce gene mutations the plate incorporation test (experiment I and II) was performed with the Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 102.
In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation.Methods
In a reverse gene mutation assay in bacteria, strains TA 98, TA 100, TA 1535, TA 1537 and TA 102 of S. typhimurium were exposed to C16-22-(even numbered)alkylamines at concentrations of 3.16, 10.0, 31.6, 100, 316 and 1000 µg/plate (experiment I), in the presence and absence of mammalian metabolic activation according to the plate incorporation method (experiment I and II).
In experiment II the test item was tested a concentrations of 1.58, 5.00. 15.8, 50.0, 158, 500 and 1000 µg/plate in all tester strains used, except for TA 98 (without metabolic activation - highest concentration: 500 µg/plate). Testing up to the limit concentration of 5000 µg/plate was not possible due to strong precipitation which interfered with evaluation. Positive, negative and sovent controls were conducted to ensure validity of experimental conditions for all tester strains.
Results & Discussion
The positive controls induced the appropriate vaild responses in the corresponding strains. The reference mutagens induced a ,distinct increase of revertant colonies indicating the validity of the experiments. Negative and solvent controls showed appropriate and valid response when compared with historical control data.
Precipitation of the test item was observed in all tester strains used in experiment I and II. In experiment I precipitation of the test item was found at a concentration of 316 ug/plate and higher (with and without metabolic activation), in experiment II precipitation of the test item was found at a concentration of 500 ug/plate and higher (with and without metabolic activation). Toxic effects of the test item were noted in all tester strains evaluated in experiment I and II.
In experiment I toxic effects of the test item were observed in tester strain TA 98 at a concentration of 1000 ug/plate (with and without metabolic activation). In tester strain TA100 toxic effects of the test item were seen at a concentration of 1000 ug/plate (without metabolic activation). In tester strains TA 1535, TA 1537 and TA 102 toxic effects ofthe test item were noted at concentrations of 316 j..tg/plate and higher (without metabolic activation). In experiment II toxic effects of the test item were noted in tester strain TA 98 at a concentration of 500 ug/plate (without metabolic activation) and at a concentration of 1000 ug/plate (with metabolic activation). In tester strains TA 100 and TA 1535 toxic effects ofthe test item were noted at concentrations of 158 ug/plate and higher (without metabolic activation). In tester strain TA 1537 toxic effects of the test item were observed at concentrations of 500 ug/plate and higher (without metabolic activation) and at a concentration of 1000 ug/plate (with metabolic activation). In tester strain TAI02 toxic effects ofthe test item were observed at a concentrations of 1000 ug/plate (without metabolic activation). The reduction in the number of revertants down to a mutation factor of 0.5 found in experiment II in tester strain TA 98 at a concentration of 50.0 ug/plate (without metabolic activation) was regarded as not biologically relevant due to lack of a dose-response relationship.
No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with C16-22-(even numbered)alkylamines at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II.In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, C16-22-(even numbered)alkylamines did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. There was no evidence of induced mutant colonies over background in any of the bacterial strains tested with the test material. Therefore, C16-22-(even numbered)alkylamines is considered to be non-mutagenic in this bacterial reverse mutation assay.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OPPTS 870.5100; OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
